Wörwag Pharma: Competence in Biofactors

Wörwag Pharma GmbH & Co. KG is a pharmaceutical company with subsidiaries worldwide. The company develops and sells biofactor preparations. Biofactors are e. g. vitamins, minerals, and trace elements.

The range of products of Wörwag Pharma comprises both prescription preparations and over the counter (OTC) products and food supplements. Most of the products, which are sold exclusively in pharmacies, are used to treat diabetic comorbidities such as neuropathy (nerve damage) as well as cardiovascular and neurological diseases.

In 2019, the company with a staff of 1,000 employees in more than 35 countries achieved sales of 234 million euros.

Wörwag Pharma is a family-owned company led by Gerhard Mayer and Jochen Schlindwein.

Dr. Fritz Wörwag founded the company in Stuttgart in 1971. Its headquarters are in Böblingen.

Getting closer. Helping better.

Our Mission

We empower health-conscious people with highly effective solutions to prevent and treat lifestyle diseases.

Our Claim

In our core therapy areas such as diabetic comorbidities and neuralgia, we are "top of mind" for our target groups.
Patients benefit from our solutions. Doctors and pharmacists appreciate our reliability and competence.
We bring successful innovations to the market and are active worldwide.

Our Values

We are responsible!
We are result-oriented!
We are customer-oriented!
We enjoy our work!

Company founder
Dr. Fritz Wörwag

1971Foundation of Wörwag Pharma in

1981 Company starts marketing of magnerot Classic and developing of biofactors in Germany

1993International expansions starts in Hungary launch of the generic product line

Generational change: Monika Wörwag and
Dr. Marcus Wörwag take over the management

2015Spin-off of the German generics of Wörwag Pharma into AAA Pharma GmbH

2019 Siblings retire from management.
New management:
Gerhard Mayer,
Jochen Schlindwein

1965City pharmacy opened in Zuffenhausen

since 1994 Consistent development of international markets in Eastern Europe and Central Asia

1996 Move to current company headquarter
in Böblingen

2001

since 2010 Expansion to South America and Asia

2016Foundation of sales-companies in Russia, Poland and Peru

2021Addition to the management team:
Dr. Lucia Cinque becomes CINO

Acquisition of own production,
Relocation to the new headquarters

Memberships

Our Locations

In more than 35 countries, we are already doing business successfully. Our aim is to expand further, above all in Asia and Latin America. We will do this with economic reason – and with our feet on the ground of our Swabian home.